SUMMARY: The Florence Statement on Triclosan and Triclocarban documents a consensus of more than 200 scientists and medical professionals on the hazards of and lack of demonstrated benefit from common uses of triclosan and triclocarban.
Trevor Lawley and Gordon Dougan are bug hunters, albeit not the conventional kind.
Eric J. Topol, MD; Ed Yong, MPhil, DISCLOSURES : Eric J. Topol, MD: Hello. I am Eric Topol. I am editor-in-chief of Medscape. I am really privileged today to have Ed Yong with me,
By Candida Fink, MD: Can the bacterial community that lives in your gut actually be related to psychiatric illnesses such as schizophrenia and bipolar disorder?
Nelly Amenyogbe, Tobias R. Kollmann and Rym Ben-Othman: Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system.
Where is the microbiome-based therapeutics market headed? A Charles River Think Tank explores the possibilities for changing how we treat disease.
Thursday, June 8, 2017 at 11 a.m. ET/5 p.m. CET Presented by: Kenneth Klingenberg Barfod, cand.scient.bio, PhD at National Research Centre for the Working Environment
A panel of experts at Microbiome Invest in London discussed the unlimited applications of the microbiome and how emerging companies may have a big impact on healthcare.
The microbiome–the collection of bacteria that live in and on you–appears headed for the big time.
There is a real move to suggest that the influence of the immune system is because of bacteria in the gut. Every science meeting has a session on it.
Gaines, Sara MD; Alverdy, John C. MD: Critical Care Medicine, Editorials: Providing normal feces to the intestinal tract of a patient suffering from life-threatening infection dates back to the fourth century when the Chinese medical literature described treating food poisoning with fecal material known as “golden soup (1).”
In the pipeline: Derek Lowe’s commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. For the last few years, it has been impossible to escape talk of the microbiome – the associated bacteria (and other organisms) that live in and on the human body.
From Meghan M. McBride, PhD: Germ-free mice are not new. Taconic Biosciences first started raising germ-free mice in 1960, after learning axenic husbandry techniques from the Laboratories of Bacteriology at the University of Notre Dame (LOBUND), where the first germ-free facility was established.
Posted on May 18, 2017 by Dr. Francis Collins: Microbes that live in dirt often engage in their own deadly turf wars, producing a toxic mix of chemical compounds (also called “small molecules”) that can be a source of new antibiotics.
CHICAGO (GenomeWeb) – BiomX, a startup focused on microbiome therapeutics via a proprietary microbiome modulation technology platform, said today that it has raised $24 million in Series A venture capital.
Courtney Reyers: Washington, DC – May 8, 2017 – Three teams of researchers will be the recipients of the Kavli Microbiome Ideas Challenge that supports novel, cross-cutting tools and methods in the field of microbiome research.
Two studies came out from the Framingham Heart Study database by the same authors in 2 different journals, one on the association between consuming artificially-sweetened beverages
Andreas J. Bäumler Department of Medical Microbiology and Immunology, School of Medicine, University of California Davis Text During the “golden age of microbiology”, the schools of Robert Koch and Louis Pasteur identified pathogenic microorganisms as the causative agents for many communicable human diseases.
This is a blog post by Nicholas Staropoli, originally posted at the Epigenetics Literacy Project on April 18, 2017. It’s reposted here with permission. The post deals with the issue of hype,
James Vitale, Marketing Program Director: This year was the 3rd year of the Translational Microbiome Conference held in Boston, Massachusetts. Boston is a major hub of microbiome research in academia, biotech, and pharma industries.